Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Company in the news

Japfa's China-focused milk business to split off for own listing in Hong Kong

The Edge Singapore
The Edge Singapore • 2 min read
Japfa's China-focused milk business to split off for own listing in Hong Kong
"Japfa Animal Protein has emerged stronger from the Covid-19 down-cycle," says CEO Tan Yong Nang / Samuel Isaac Chua of The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Japfa’s milk-producing business in China, AustAsia Investment Holdings, has applied for its listing in Hong Kong, which will result in two separately run entities with more flexibility and better focus to grow their respective businesses.

As part of the IPO, existing Japfa shareholders will receive a distribution of AIH shares in specie, potentially resulting in Japfa shareholders holding shares worth more than what Japfa shares are trading at now.

The number of AIH shares to be distributed to Japfa shareholders is to be determined.

This deal is subjected to approval by shareholders at an EGM to be called.

Following the listing of AIH, the remaining business, Japfa Animal Protein will continue to run its animal feed and chicken, beef and seafood farms in Indonesia under Jakarta-listed PT Japfa Comfeed Indonesia. Japfa will also continue to hold its pig farming business in Vietnam as well as similar but smaller ones in India, Myanmar and Bangladesh.

With its own listing, AIH will have another avenue to access capital to further grow its dairy business in China, while Japfa can better focus its financial resources on the remaining businesses.

See also: Sembcorp issues $350 mil of guaranteed notes due 2036 at 3.65%

Tan Yong Nang, Japfa’s executive director and CEO calls the separation of AIH and Japfa a “watershed moment”.

“Japfa Animal Protein has emerged stronger from the Covid-19 down-cycle and played an important role in providing food security and minimising disruption to the supply chain in countries that it operates in,” he says.

“We are confident Japfa Animal Protein is well-positioned in shaping the animal protein industry with a multi-year runway to take advantage of the growth opportunities in these countries,” adds Tan.

See also: Yangzijiang Shipbuilding subsidiaries have ‘reasonably good prospect of success’ in arbitration claims

Upon completion of the split, Japfa Animal Protein would have a pro forma FY2021 revenue of more than US$4 billion with a corresponding Ebitda of US$374 million.

According to Japfa, based on recent transactions of stakes in AIH late last year, Japfa’s 62.5% stake in AIH is worth $992 million, or 49 cents per Japfa share. Its stake in PT Japfa Tbk is similarly valued at 49 cents per Japfa share, using the Indonesia-listed entity’s current market value as a gauge.

In contrast, Japfa closed March 29 at 65 cents, up 0.78% for the day and up 4.84% year to date.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.